Molecular features and expression of DAZAP2 in human multiple myeloma.

Chin Med J (Engl)

Molecular Biology Research Center, School of Biological Science and Technology, Central South University, Changsha 410078, China.

Published: October 2007

Background: In our previous study, we found that DAZAP2 was the most significantly down regulated gene when differential screening of complementary DNA (cDNA) chips were used to analyze mRNA isolated from bone marrow mononuclear cells from newly diagnosed multiple myeloma (MM) patients without anticancer treatment. In this study, we observed DAZAP2 mRNA and protein expression in the mononuclear cells from MM bone marrow and investigated its role in the pathogenesis of MM.

Methods: The full-length cDNA of DAZAP2 was cloned and sequenced from mononuclear cells from human bone marrow. The nucleotide and amino acid sequences of DAZAP2 were analyzed using the ClustalW program. A dendrogram was constructed by multiple sequence alignment using ClustalW and amino acid sequence identity/similarity was derived based on comparisons attained using the MegAlign software. The recombinant pEGFP expression vector was constructed and the confocal microscopy was used for the localization of the DAZAP2 protein in transfected COS7 cells. The expression of DAZAP2 mRNA was detected by semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) and the expression level of DAZAP2 protein was detected by Western blotting analysis in MM samples.

Results: DAZAP2 proteins of vertebrates is highly conserved in evolution. It contains a proline-rich region, several potential SH2 and SH3 domain-binding motifs and a possible protein kinase C (PKC) phosphorylation site. We showed by confocal microscopy that the DAZAP2 protein predominantly resides in the cytoplasm with a discrete pattern of punctuated distribution. The expression of DAZAP2 was not detected in 24 of 36 MM samples by semi-quantitative RT-PCR. In contrast, DAZAP2 expression was detected in all 30 normal controls. The expression level of DAZAP2 protein was assayed by Western blotting analysis, showing a robust down-regulation in MM patients (P < 0.001) that matched with the results of the RT-PCR.

Conclusions: DAZAP2 is downregulated in MM samples and it may be a signal molecule in MM cells. DAZAP2 is involved in the pathogenesis of MM and could be used as a genetic marker for MM.

Download full-text PDF

Source

Publication Analysis

Top Keywords

dazap2 protein
16
dazap2
15
expression dazap2
12
bone marrow
12
mononuclear cells
12
expression
8
multiple myeloma
8
dazap2 mrna
8
amino acid
8
confocal microscopy
8

Similar Publications

LncRNA MYOSLID contributes to PH via targeting BMPR2 signaling in pulmonary artery smooth muscle cell.

Vascul Pharmacol

December 2024

Department of Cardiology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China. Electronic address:

Background/objective: The pathogenesis and vascular remodeling during pulmonary hypertension (PH) have been associated with dysregulation of bone morphogenetic protein receptor type 2 (BMPR2) and transforming growth factor-β (TGF-β) signaling in pulmonary artery smooth muscle cells (PASMCs). Evidence suggests that the human-specific lncRNA MYOSLID is a transcriptional target of the TGF-β/SMAD pathway. In this study, we investigated the involvement of MYOSLID in the pathogenesis of PH.

View Article and Find Full Text PDF
Article Synopsis
  • The study aims to identify host anti-viral factors that can help control SARS-CoV-2 infection, which have been overlooked in previous research focused mainly on pro-viral factors.* -
  • Using a genome-wide CRISPR dropout screen, the researchers found several underappreciated host factors, such as components of V-ATPases, ESCRT, and N-glycosylation pathways, which affect viral entry and replication.* -
  • Key findings include the identification of the cohesin complex as an anti-viral pathway and the transcription factor KLF5, which is linked to severe COVID-19 symptoms, shedding light on the genetic and molecular interactions that influence the severity of the disease.*
View Article and Find Full Text PDF

METTL3-mediated RNA N6-methyladenosine (m6A) is the most prevalent modification that participates in tumor initiation and progression governing the expression of their target genes in cancers. However, its role in tumor cell metabolism remains poorly characterized. In this study, m6A microarray and quantitative proteomics were employed to explore the potential effect and mechanism of METTL3 on the metabolism in GC cells.

View Article and Find Full Text PDF

Purpose: The specific mechanisms and biomarkersunderlying the progression of stable coronary artery disease (CAD) to acute myocardial infarction (AMI) remain unclear. The current study aims to explore novel gene biomarkers associated with CAD progression by analyzing the transcriptomic sequencing data of peripheral blood monocytes in different stages of CAD.

Material And Methods: A total of 24 age- and sex- matched patients at different CAD stages who received coronary angiography were enrolled, which included 8 patients with normal coronary angiography, 8 patients with angiographic intermediate lesion, and 8 patients with AMI.

View Article and Find Full Text PDF

DAZAP2 acts as specifier of the p53 response to DNA damage.

Nucleic Acids Res

March 2021

Institute of Toxicology, University Medical Center Mainz, Johannes Gutenberg University, Mainz, Germany.

Article Synopsis
  • - The study identifies Deleted in Azoospermia-associated protein 2 (DAZAP2) as a new regulator of HIPK2 and its influence on the p53 response to DNA damage, which is important for cancer therapy.
  • - By knocking down or deleting DAZAP2, researchers found that cancer cells became more sensitive to chemotherapy, as shown in experiments with both cell cultures and mouse models.
  • - DAZAP2 normally helps degrade HIPK2 in unstressed cells and, after DNA damage, it changes its role to assist p53 in regulating certain genes vital for the cellular response to damage, suggesting its potential as a target for improving cancer treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!